Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial)
British Journal of Surgery · 24.12.2025 · 113 (1)
DOI: 10.1093/bjs/znaf286 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 27.01.2026. Verfasst von Sanjiv S G Gangaram Panday und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Quality of Life, Watchful Waiting, Esophagectomy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Dutch Cancer Society, Netherlands Organization for Health Research and Development.
Abstract (Originalsprache)
Background
The SANO trial demonstrated that active surveillance after neoadjuvant chemoradiotherapy (nCRT) has non-inferior 2-year overall survival compared with standard surgery in patients with locally advanced oesophageal cancer. This aim of this study was to compare health-related quality of life (HRQoL) in both groups.
Methods
Patients with a cCR after nCRT were included and randomized within the stepped-wedge cluster-randomized SANO trial to active surveillance or surgery. HRQoL was measured using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 (QLQ-C30) and the EORTC Quality of Life Questionnaire-Oesophago-Gastric Module (QLQ-OG25) before nCRT (baseline) and at 3 (before surgery), 6, 9, 12, 16, 20, and 24 months after nCRT. Predefined endpoints included dysphagia (QLQ-OG25), as well as dyspnoea, fatigue, physical functioning, and emotional functioning (all QLQ-C30). Repeated measures analysis was used to assess between-group differences. Cohen’s d (CD) >0.5 was considered clinically relevant.
Results
A total of 274 patients were included, with a response rate of 85.4% (234 patients responded in total; 169 active surveillance patients and 65 standard surgery patients). At 6 months after nCRT, scores for dysphagia, dyspnoea, fatigue, and physical functioning were significantly better in the active surveillance group (CD of −1.09, −0.63, −0.70, and 0.77 respectively; all P ≤ 0.001). Dysphagia remained significantly better in the active surveillance group at 9, 12, and 24 months after nCRT (CD of −0.60 (P = 0.001), −0.46 (P = 0.015), and −0.79 (P < 0.001) respectively). No differences were found for other domains.
Conclusion
Active surveillance patients experienced less dysphagia, dyspnoea, and fatigue, as well as better physical functioning, at 6 months after nCRT compared with standard surgery patients. Dysphagia remained improved at 2 years. These results support an active surveillance approach in patients with oesophageal cancer who attain a cCR after nCRT. Registration number NTR-6803 (Netherlands Trial Register).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, The Netherlands.
- Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Department of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
- Department of Surgery, ZGT Hospital, Almelo, The Netherlands.
- Department of Surgery, Reinier de Graaf Gasthuis, Delft, The Netherlands.
ORCID-Profile: Berend J van der Wilk, Camiel Rosman, Bo J Noordman, Maria J Valkema, Michail Doukas, Olga Husson, Bastiaan Klarenbeek, Misha D Luyer, Bianca Mostert, Grard A P Nieuwenhuijzen, Manon C W Spaander, Bas P L Wijnhoven
Förderung
- Dutch Cancer Society
- Netherlands Organization for Health Research and Development
Zitieren
APA
Gangaram Panday, S. S. G., van der Wilk, B. J., Eyck, B. M., Lagarde, S. M., Rosman, C., Noordman, B. J., Valkema, M. J., Bisseling, T. M., Coene, P. L. O., van Det, M. J., Dekker, J. W. T., van Dieren, J. M., Doukas, M., van Esser, S., Fiets, W. E., Hartgrink, H. H., Heisterkamp, J., Holster, I. L., Husson, O., …, & Other Members of the SANO Study Group (2025). Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial). British Journal of Surgery, 113(1). https://doi.org/10.1093/bjs/znaf286
Vancouver
Gangaram Panday SSG, van der Wilk BJ, Eyck BM, Lagarde SM, Rosman C, Noordman BJ, et al. Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial). British Journal of Surgery. 2025;113(1). doi:10.1093/bjs/znaf286
BibTeX
@article{GangaramPanday2025,
author = {Gangaram Panday, Sanjiv S G and van der Wilk, Berend J and Eyck, Ben M and Lagarde, Sjoerd M and Rosman, Camiel and Noordman, Bo J and Valkema, Maria J and Bisseling, Tanya M and Coene, Peter-Paul L O and van Det, Marc J and Dekker, Jan W T and van Dieren, Jolanda M and Doukas, Michail and van Esser, Stijn and Fiets, W Edward and Hartgrink, Henk H and Heisterkamp, Joos and Holster, I Lisanne and Husson, Olga and Klarenbeek, Bastiaan and Kouw, Eva and Kouwenhoven, Ewout A and Luyer, Misha D and Mostert, Bianca and Nieuwenhuijzen, Grard A P and Oostenbrug, Liekele E and Pierie, Jean-Pierre and van Sandick, Johanna W and Sosef, Meindert N and Spaander, Manon C W and Steyerberg, Ewout W and Valkema, Roelf and van der Zaag, Edwin S and Lingsma, Hester F and van Klaveren, David and van Lanschot, J Jan B and Wijnhoven, Bas P L and Other Members of the SANO Study Group, Other Members of the SANO Study Group},
title = {Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial)},
journal = {British Journal of Surgery},
year = {2025},
volume = {113},
number = {1},
doi = {10.1093/bjs/znaf286}
}
EUVIMED